Cargando…
A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study
OBJECTIVE: To examined the impact of reproductive factors on the relationship between radiation treatment (RT) for a first breast cancer and risk of contralateral breast cancer (CBC). METHODS: The Women’s Environmental Cancer and Radiation Epidemiology (WECARE) Study is a multi-center, population-ba...
Autores principales: | Brooks, Jennifer D., Boice, John D., Shore, Roy E., Reiner, Anne S., Smith, Susan A., Bernstein, Leslie, Knight, Julia A., Lynch, Charles F., John, Esther M., Malone, Kathleen E., Mellemkjær, Lene, Langballe, Rikke, Liang, Xiaolin, Woods, Meghan, Tischkowitz, Marc, Concannon, Patrick, Stram, Daniel O., Bernstein, Jonine L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494790/ https://www.ncbi.nlm.nih.gov/pubmed/32927238 http://dx.doi.org/10.1016/j.breast.2020.07.007 |
Ejemplares similares
-
Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
por: Langballe, Rikke, et al.
Publicado: (2016) -
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population
por: Reiner, Anne S., et al.
Publicado: (2017) -
Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study
por: Sisti, Julia S., et al.
Publicado: (2015) -
Machine learning on genome-wide association studies to predict the risk of radiation-associated contralateral breast cancer in the WECARE Study
por: Lee, Sangkyu, et al.
Publicado: (2020) -
CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study
por: Brooks, Jennifer D., et al.
Publicado: (2018)